Clinical Trials Browser

Phase 1 × Adenocarcinoma × Vaccines × Clear all

NCT01730118 2022-09-10

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

Phase 1 Completed

33 enrolled 18 charts

Adenocarcinoma, Breast Neoplasms